Patents Assigned to REJUKON BIOPHARM INC.
  • Compositions and methods for dissolving protein aggregates
    Patent number: 11970517
    Abstract: The present disclosure provides a polypeptide capable of dissolving protein aggregates. Also provided is a method of treating a neurodegeneration disease using the polypeptide.
    Type: Grant
    Filed: August 14, 2022
    Date of Patent: April 30, 2024
    Assignee: REJUKON BIOPHARM INC.
    Inventor: Chenchen Wang